ABOUT US
A global leader in innovative genomic
technology and diagnostic tests.

What’s new at Agendia?
Get the latest updates on our company and products, as well as new developments in genomic science.
News
In the News
News
Media Releases
New Research to be Presented at SABCS 2018 Reinforces MammaPrint and BluePrint Testing to Guide Breast Cancer Treatment Management Decisions
PRESS RELEASE Agendia Announces New Research Reinforcing MammaPrintยฎ and BluePrintยฎ Testing to Guide Breast Cancer Treatment Management Decisions Across Different Patient Populations and Ages at the 2018 San Antonio Breast Cancer Symposium IRVINE, CA, AMSTERDAM, Read More
Oncology Consultants Joins Agendiaโs FLEX Big Data Registry Study
PRESS RELEASE Oncology Consultants Join Agendiaโs FLEX Big DataRegistry Study, Helping to Build a Unique Resource for Breast Cancer Research All Oncology Consultants practices participate in the initiative, matching full genome profiles with complete clinical Read More
Latest Results from the I-SPY 2 Trial at the EORTC-NCI-AACR Symposium Demonstrate Ability of MammaPrintยฎ and BluePrintยฎ to Predict Treatment Response in Breast Cancer Patients
ย PRESS RELEASE Latest Results from the I-SPY 2 Trial at the EORTC-NCI-AACR Symposium Demonstrate Ability of MammaPrintยฎ and BluePrintยฎ to Predict Treatment Response in Breast Cancer Patients New data from the trial shows that a Read More
Agendia Announces Level 1 Inclusion of MammaPrintยฎ Breast Cancer Test in Updated National Comprehensive Cancer Networkยฎ (NCCN) Guidelines
PRESS RELEASE Agendia Announces Level 1 Inclusion of MammaPrintยฎ Breast Cancer Test in Updated National Comprehensive Cancer Networkยฎ (NCCN) Guidelines The NCCN recommends Agendiaโs MammaPrintยฎ breast cancer test with the highest level of evidence for Read More